A contentious proposal from the Centers for Medicare & Medicaid Services (CMS) aimed at restructuring reimbursement for outpatient services has ignited a firestorm of opposition from the medical community. The rule, which targets payments for secondary services performed during the same visit as an Evaluation and Management (E/M) encounter, is being decried by industry leaders as an unsubstantiated, arbitrary, and potentially harmful shift in healthcare delivery that could compromise patient access to essential, same-day care.
The Core of the Proposal: The "Modifier 25" Rule
Under the newly proposed federal regulations, CMS seeks to overhaul how it compensates physicians when multiple services are billed on the same day. Currently, physicians use "Modifier 25" to indicate that a significant, separately identifiable E/M service was performed on the same day as a procedure. This allows for both services to be billed and reimbursed appropriately.
The new proposal, outlined in a July 16 Federal Register notice, mandates a radical change: if two or more services are performed on the same day, only the most expensive service—whether it be the surgical procedure or the E/M visit—will be reimbursed at the full 100% rate. Every other subsequent service, regardless of its clinical complexity or necessity, would be subject to a 50% payment reduction.
CMS argues that the current payment methodology likely leads to redundant payments. In its proposal, the agency noted, "We continue to believe that there are efficiencies when the same physician provides an E/M service for the same patient in conjunction with a procedure… and that we are likely duplicating payment under the current payment methodology."
A Brief History: From 2019 to the Present
This is not the first time the medical community has grappled with this specific policy. The proposal is a resurrected version of a policy originally introduced in 2019. At that time, facing intense lobbying and a lack of supporting data, the agency ultimately withdrew the plan.
The current reintroduction of the policy has been met with shock by stakeholders who believed the matter had been settled. Following the public comment period, which concluded on Monday, the industry now sits in a state of high-stakes anticipation. CMS is legally required to issue a final rule by November 1. This final ruling could see the proposal adopted in its entirety, modified to include smaller cuts (such as the 25% reduction mentioned as an alternative in the proposal), or discarded completely.
Supporting Data and the Burden of Proof
The central grievance of the medical community—led by the American Medical Association (AMA), the Medical Group Management Association (MGMA), and 150 other organizations—is the lack of empirical evidence supporting CMS’s claims of "efficiency" or "duplication."
In a scathing joint letter addressed to CMS Administrator Mehmet Oz, MD, MBA, the coalition argued that the agency is advancing policy based on an "unsubstantiated assumption." The letter emphasizes that such a significant shift in healthcare financing requires rigorous data, which CMS has failed to provide.
"CMS already possesses numerous ways to deal with duplication," noted Anders Gilberg, senior vice president for government affairs at the MGMA. Gilberg points to the RBRVS Update Committee (RUC), which currently makes granular recommendations regarding payment rates to account for service overlap. Furthermore, CMS already utilizes a "misvalued code initiative" specifically designed to identify and correct instances of overpayment. Critics argue that adding a blanket 50% cut is a blunt instrument that ignores the nuances of modern clinical practice.
Clinical Implications: The Fragility of Independent Practices
The economic impact of the proposal is expected to be profound, particularly for independent medical practices that operate on thin margins. The proposed cuts are not merely a matter of bookkeeping; they threaten the operational viability of small and medium-sized practices that rely on the ability to provide comprehensive, same-day care.
The "Same-Day" Paradox
Medical experts argue that the policy creates a perverse incentive that harms both the patient and the healthcare system. Dr. Rick Snyder, a cardiologist and vice president of the American Independent Medical Practice Association (AIMPA), provided a stark example of how this would play out in practice:
"Imagine a patient comes in for a routine melanoma screening. The dermatologist identifies a suspicious lesion that requires an immediate biopsy or removal. Under the current system, the physician can handle that during the same visit. Under the new proposal, the physician is penalized 50% for doing both."
Dr. Snyder points out the irony: while CMS intends to save money through these cuts, they are effectively punishing physicians for preventing long-term, high-cost complications. "The same-day procedure could potentially save Medicare hundreds of thousands of dollars by avoiding advanced surgery or immunotherapy for late-stage cancer," he explained. By forcing a choice between financial viability and patient care, the proposal may drive physicians to split care into multiple visits, which increases costs for the Medicare program and creates significant burdens for patients who must travel to clinics repeatedly.
Impact on Specific Specialties
The damage will not be distributed evenly across the medical field. Specialties that frequently utilize same-day procedures—including dermatology, ophthalmology, otolaryngology, and rheumatology—are expected to face the brunt of the financial losses. For these practices, the "Modifier 25" encounter is the standard of care, not an outlier.
Official Responses and Political Pressure
The opposition has been unified and swift. The letter to Administrator Oz highlights a growing concern that, despite the current administration’s stated commitment to supporting independent practices, this policy will have the opposite effect.
"We appreciate the administration’s emphasis on keeping independent physician practices sustainable," the coalition wrote, "yet we believe the unintended consequence of CMS’s proposed policy will make it extremely difficult for those practices to remain viable."
Beyond the letters and formal comments, there is growing movement on Capitol Hill. Dr. Snyder notes that many lawmakers are beginning to understand that this proposal could be a catalyst for further consolidation in the healthcare industry. As independent practices struggle to balance their books, many may be forced to sell to large hospital systems or private equity-backed groups, a trend that critics argue leads to higher costs and decreased competition.
"There is a lot of unanimity that CMS should walk this back," Dr. Snyder said. "We are getting signs that CMS is listening, but we are anxiously waiting to see what the final rule shows."
The Path Forward: What Happens Now?
As the November 1 deadline approaches, the healthcare sector is bracing for a potential paradigm shift. The outcome will depend on whether CMS views the potential for cost savings as outweighing the outcry from the clinical community.
If the rule is implemented, the industry expects a ripple effect:
- Administrative Overhead: Practices will need to invest heavily in new billing software and staff training to mitigate the impact of the payment cuts.
- Reduced Access: Patients may find it increasingly difficult to receive comprehensive care in a single visit, leading to longer wait times and more frequent appointments.
- Market Consolidation: Smaller, independent practices may close or be acquired, further reducing competition and potentially increasing the total cost of care within the Medicare system.
Ultimately, the controversy over the modifier 25 rule serves as a microcosm of the broader struggle between federal fiscal oversight and the reality of clinical operations. As the agency weighs its options, the message from the medical community remains clear: policy must be driven by data, not by assumptions, and it must never lose sight of the patient’s need for timely, accessible, and high-quality care.
Whether CMS will maintain its course or heed the advice of the experts who work on the front lines of American healthcare remains to be seen. For now, the medical community remains on high alert, preparing for a potential final rule that could redefine the economics of the physician office for years to come.
